However, many neurodevelopmental disorders, such as Angelman syndrome, have a critical window [24,25] that may limit the effectiveness of therapeutics like UBE3A reinstatement in adults, where neuronal circuits are already established and compromised [9,10,11,12,13,24,25,26,27]. Here, UBE3A is linked to Angelman syndrome.